Cart
sales@molnova.com
Elagolix sodium
CAS No. 832720-36-2
Elagolix sodium ( NBI-56418 sodium )
Catalog No. M20990 CAS No. 832720-36-2
Elagolix sodium is a GnRH receptor (GnRHR) antagonist ( IC50 and Ki of 0.25 and 3.7 nM respectively).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 34 | In Stock |
|
| 5MG | 55 | In Stock |
|
| 10MG | 87 | In Stock |
|
| 25MG | 158 | In Stock |
|
| 50MG | 258 | In Stock |
|
| 100MG | 402 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameElagolix sodium
-
NoteResearch use only not for human use.
-
Brief DescriptionElagolix sodium is a GnRH receptor (GnRHR) antagonist ( IC50 and Ki of 0.25 and 3.7 nM respectively).
-
DescriptionElagolix sodium is a GnRH receptor (GnRHR) antagonist ( IC50 and Ki of 0.25 and 3.7 nM respectively).
-
SynonymsNBI-56418 sodium
-
PathwayOthers
-
TargetOther Targets
-
RecptorGNRHR
-
Research AreaCancer
-
IndicationUterine leiomyoma
Chemical Information
-
CAS Number832720-36-2
-
Formula Weight653.57
-
Molecular FormulaC32H29F5N3NaO5
-
Purity>98% (HPLC)
-
SolubilityDMSO:50 mg/mL (76.50 mM); H2O:50 mg/mL (76.50 mM)
-
SMILESCOc1cccc(-c2c(C)n(Cc3c(F)cccc3C(F)(F)F)c(=O)n(CC(NCCCC(=O)[O-])c3ccccc3)c2=O)c1F.[Na+]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Barra F Scala C Ferrero S2.Elagolix sodium for the treatment of women with moderate to severe endometriosis-associated pain.Drugs Today (Barc). 2019 Apr;55(4):237-246.
molnova catalog
related products
-
Evodol
Evodol may as an anti-inflammatory agent or lead compound, it shows inhibitory activity on nitric oxide (NO) production in lipopolysaccharide -activated RAW264.7 macrophages.
-
(E)-Tonghaosu
The herbs of Glebionis coronaria.
-
Jagged-1 (188-204) T...
Jagged-1 (188-204) TFA is a fragment of the JAG-1 protein. JAG-1 is Notch ligand, a peptide that is the most conspicuously expressed ligand in skin. JAG-1 induces epidermal maturation. Exposing submerged keratinocytes monolayers to JAG-1 with elevated calcium concentration produces stratification with loricrin expression and NF-alphaB activation.
